113 related articles for article (PubMed ID: 2993497)
1. Inhibition of in vitro HBsAg production by amphotericin B and ketoconazole.
Pottage JC; Kessler HA
J Med Virol; 1985 Jul; 16(3):275-81. PubMed ID: 2993497
[TBL] [Abstract][Full Text] [Related]
2. [Effects of extracts from Phyllanthus urinaria L. on HBsAg production in PLC/PRF/5 cell line].
Ji XH; Qin YZ; Wang WY; Zhu JY; Liu XT
Zhongguo Zhong Yao Za Zhi; 1993 Aug; 18(8):496-8, 511. PubMed ID: 8011099
[TBL] [Abstract][Full Text] [Related]
3. Lack of specific effect of adenine arabinoside, human interferon, and ribavirin on in vitro production of hepatitis B surface antigen.
Lemon SM; Bancroft WH
J Infect Dis; 1979 Nov; 140(5):798-801. PubMed ID: 528792
[TBL] [Abstract][Full Text] [Related]
4. Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity.
Kessler HA; Pottage JC; Trenholme GM; Benson CA; Levin S
AIDS Res; 1986 Feb; 2(1):63-72. PubMed ID: 2424468
[TBL] [Abstract][Full Text] [Related]
5. Effect of human leukocyte interferon on HBsAg production in PLC/PRF/5 human hepatoma cell line.
Hajnická V; Stancek D
Acta Virol; 1987 Sep; 31(5):404-9. PubMed ID: 2891279
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B surface antigen produced by a human hepatoma cell line.
MacNab GM; Alexander JJ; Lecatsas G; Bey EM; Urbanowicz JM
Br J Cancer; 1976 Nov; 34(5):509-15. PubMed ID: 187208
[TBL] [Abstract][Full Text] [Related]
7. Production of hepatitis B virus surface antigen particles by the human hepatoma cell line huGK-14 in a serum-free medium.
Koike K; Yoshida E; Katagiri K; Katayanagi M; Oda M; Tsunoo H; Yaginuma K; Kobayashi M
Jpn J Cancer Res; 1987 Dec; 78(12):1341-6. PubMed ID: 2828295
[TBL] [Abstract][Full Text] [Related]
8. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
9. Modulation of production of hepatitis B surface antigen by a human hepatoma cell line.
Clementi M; Bagnarelli P; Pauri P; Calegari L
J Med Virol; 1984; 13(2):117-23. PubMed ID: 6198456
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B therapy, hepatocellular carcinoma and HBsAg mutants.
Marzano A; Marengo A; David E; Rizzetto M
Dig Liver Dis; 2013 Jun; 45(6):525-7. PubMed ID: 23415581
[No Abstract] [Full Text] [Related]
11. Effect of steroids and adenine-arabinoside (araA) on growth and HBsAg production of a human hepatoma cell line.
Clementi M; Bagnarelli P; Pauri P
Arch Virol; 1983; 75(1-2):137-41. PubMed ID: 6187317
[No Abstract] [Full Text] [Related]
12. Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line.
Hajnická V; Fuchsberger N; Liptáková H; Stancek D; Kontsek P
Acta Virol; 1996 Sep; 40(4):221-2. PubMed ID: 9014013
[TBL] [Abstract][Full Text] [Related]
13. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
[TBL] [Abstract][Full Text] [Related]
14. Detection of HBsAg in a clone derived from the PLC/PRF/5 human hepatoma cell line.
Wen YM; Copeland JA; Mann GF; Howard CR; Zuckerman AJ
Arch Virol; 1981; 68(3-4):157-63. PubMed ID: 6268017
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural analysis of hepatitis B surface antigen production in vitro.
Aoki N; Thung SN; Gerber MA
Lab Invest; 1982 Nov; 47(5):465-70. PubMed ID: 6182389
[TBL] [Abstract][Full Text] [Related]
16. Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5).
Barin F; Goudeau A; Brechot C; Romet-Lemonne J; Sureau C; Lesage G
Dev Biol Stand; 1983; 54():81-92. PubMed ID: 6317496
[TBL] [Abstract][Full Text] [Related]
17. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HBsAg secretion from Alexander cell line by Phyllanthus amarus.
Jayaram S; Thyagarajan SP
Indian J Pathol Microbiol; 1996 Jul; 39(3):211-5. PubMed ID: 8972151
[TBL] [Abstract][Full Text] [Related]
19. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.
Yamashita Y; Koike K; Takaoki M; Matsuda S
Microbiol Immunol; 1988; 32(11):1119-26. PubMed ID: 2464737
[TBL] [Abstract][Full Text] [Related]
20. Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study.
Takahara T; Watanabe A; Shiraki K
J Hepatol; 1994 Oct; 21(4):601-9. PubMed ID: 7814808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
